SOLV Energy, Inc. (MWH) Q1 2026 Earnings Call Transcript
SOLV Energy, Inc. (MWH) Q1 2026 Earnings Call Transcript
SOLV - Solventum Corporation
SOLV Energy, Inc. (MWH) Q1 2026 Earnings Call Transcript
Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SOLV Energy NASDAQ: MWH reported sharply higher first-quarter revenue and adjusted earnings, raised its full-year profit outlook and said demand for solar, storage and grid infrastructure remains strong as U.S. power needs accelerate.
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a long-term bullish trend.
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the first quarter ended March 31, 2026. Financial Summary (in $ millions except percentages) Three Months Ended March 31, 2026 2025 Revenue 677 408 Gross Profit 119 59 Gross Margin 17.6% 14.5% Net Loss 1 (27) (1) Adjusted Gross Profit 2 124 59 Adjusted Gross Margin 2 18.4% 14.5% Adjusted EBITDA 93 34 1) Represents Net Loss before Non-Controlling Interest 2) Adjusted Gross Profit and Adjusted Gross Margin exclude the impact of the allocation of non-cash compensation expense to cost of revenue First Quarter 2026 Financial and Recent Business Highlights Revenue of $677 million, up 66% year over year Gross Profit of $119 million, up 102% year over year Adjusted Gross Profit of $124 million, up 110% year over year Net loss of $(27) million Primarily a result of a one-time, non-cash expense of $521 million related to the modification of legacy equity awards from the reorganization in the IPO Adjusted EBITDA of $93 million, up 174% year over year Total backlog as of March 31, 2026 at $8.2 billion Nearly 22 GW under contract for O&M services Announced the acquisition of Roberson Waite Electric (“RWE”) providing the Company additional capabilities and growth opportunities in the utility services market 1) Included in total non-cash compensation expense in cost of revenue and SG&A of approx.
ST. PAUL, Minn., May 7, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, beginning at approximately 10:00 a.m.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 20-day moving average, which suggests a short-term bullish trend.
From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript
Solventum (SOLV) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.34 per share a year ago.
While the top- and bottom-line numbers for Solventum (SOLV) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for its wound care and sterilization products.
Reported sales decreased (3.0)%; organic sales increased 2.1% Affirms full-year 2026 organic sales growth and free cash flow guidance; estimates adjusted EPS will be toward the high end of existing range EAGAN, Minn., May 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2026.
SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report first quarter 2026 results on Tuesday, May 12, 2026. Management will present results during a conference call at 8:30 a.m. Eastern time.
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (Nasdaq: MWH) (“SOLV”), a leading provider of infrastructure services to the power industry, today announced it has entered into an agreement to acquire Roberson Waite Electric (“RWE”), a California-based provider of utility substation construction, testing, commissioning, and related infrastructure services.
Nelson Peltz's Trian Fund Management on Thursday called on Solventum to rightsize overhead costs, divest non-core businesses and improve capital allocation in its latest appeal for a performance turnaround at the medical device maker.